SNOA - Sonoma Pharmaceuticals GAAP EPS of -$0.31 revenue of $3.01M June, 22 2023 08:58 AM Sonoma Pharmaceuticals Inc. 2023-06-22 08:58:37 ET Sonoma Pharmaceuticals press release ( NASDAQ: SNOA ): Q4 GAAP EPS of -$0.31. Revenue of $3.01M (+30.9% Y/Y). For further details see: Sonoma Pharmaceuticals GAAP EPS of -$0.31, revenue of $3.01M